Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.

Vladimír Bartoš, Milada Kullová
{"title":"Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.","authors":"Vladimír Bartoš, Milada Kullová","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Calponin is an actin filament-associated protein significantly involved in the regulation of the cellular motility. Some data have indicated that overproduction of calponin in basal cell carcinoma (BCC) of the skin may be responsible for local tumor invasiveness and more aggressive biological behavior. We studied the immunohistochemical expression of calponin in a set of cutaneous BCCs, in order to clarify whether the presence of calponin in cancer cells may be a predictor of invasive tumor growth. The study group consisted of 37 primary BCCs categorized into a non-infiltrative subgroup (5 superficial, 16 nodular subtypes) and infiltrative subgroup (9 nodular-infiltrative, 7 infiltrative subtypes). A specific monoclonal antibody against calponin was used for staining. Expression of calponin in tumor tissue was found in 72.9% (27/37) of the cases, though staining intensity was relatively weak. In superficial, nodular, nodular-infiltrative, and infiltrative BCC subtypes, calponin positivity was found in 80% (4/5), 75% (12/16), 66.7% (6/9), and 71.5% (5/7), respectively. We did not confirm a significant correlation between expression of calponin and given, non-infiltrative, and infiltrative BCC subgroups. Furthermore, we found seven BCCs (18.9%) with striking immunoreactivity for calponin in adjacent peritumorous stroma. There was a significant association between stromal immunoreactivity for calponin and tumor growth histomorphology being positive only in BCCs with infiltrative growth features. Our study has shown that neoplastic cells in cutaneous BCC commonly produce calponin regardless of histological subtype. Expression of calponin in tumor tissue was not associated with the aggressive tumor phenotype. However, since some BCCs with infiltrative growth patterns strongly expressed calponin in peritumorous stroma, this finding could more reliably reflect the biological behavior of cancer and should be better explained in the future. </p>","PeriodicalId":94367,"journal":{"name":"Acta dermatovenerologica Croatica : ADC","volume":"23 4","pages":"254-9"},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta dermatovenerologica Croatica : ADC","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Calponin is an actin filament-associated protein significantly involved in the regulation of the cellular motility. Some data have indicated that overproduction of calponin in basal cell carcinoma (BCC) of the skin may be responsible for local tumor invasiveness and more aggressive biological behavior. We studied the immunohistochemical expression of calponin in a set of cutaneous BCCs, in order to clarify whether the presence of calponin in cancer cells may be a predictor of invasive tumor growth. The study group consisted of 37 primary BCCs categorized into a non-infiltrative subgroup (5 superficial, 16 nodular subtypes) and infiltrative subgroup (9 nodular-infiltrative, 7 infiltrative subtypes). A specific monoclonal antibody against calponin was used for staining. Expression of calponin in tumor tissue was found in 72.9% (27/37) of the cases, though staining intensity was relatively weak. In superficial, nodular, nodular-infiltrative, and infiltrative BCC subtypes, calponin positivity was found in 80% (4/5), 75% (12/16), 66.7% (6/9), and 71.5% (5/7), respectively. We did not confirm a significant correlation between expression of calponin and given, non-infiltrative, and infiltrative BCC subgroups. Furthermore, we found seven BCCs (18.9%) with striking immunoreactivity for calponin in adjacent peritumorous stroma. There was a significant association between stromal immunoreactivity for calponin and tumor growth histomorphology being positive only in BCCs with infiltrative growth features. Our study has shown that neoplastic cells in cutaneous BCC commonly produce calponin regardless of histological subtype. Expression of calponin in tumor tissue was not associated with the aggressive tumor phenotype. However, since some BCCs with infiltrative growth patterns strongly expressed calponin in peritumorous stroma, this finding could more reliably reflect the biological behavior of cancer and should be better explained in the future.

皮肤基底细胞癌中钙蛋白的免疫组化表达
钙调蛋白是一种肌动蛋白丝相关蛋白,在细胞运动调节中发挥着重要作用。一些数据表明,皮肤基底细胞癌(BCC)中钙蛋白的过度生成可能是造成局部肿瘤侵袭性和更具侵袭性生物学行为的原因。我们研究了一组皮肤基底细胞癌(BCC)中钙蛋白的免疫组化表达,以明确癌细胞中钙蛋白的存在是否可预测肿瘤的侵袭性生长。研究组由 37 例原发性 BCC 组成,分为非浸润亚组(5 例浅表亚型、16 例结节亚型)和浸润亚组(9 例结节浸润亚型、7 例浸润亚型)。染色使用的是针对钙调蛋白的特异性单克隆抗体。72.9%的病例(27/37)发现肿瘤组织中有钙蛋白表达,但染色强度相对较弱。在表皮型、结节型、结节浸润型和浸润型 BCC 亚型中,钙蛋白阳性率分别为 80%(4/5)、75%(12/16)、66.7%(6/9)和 71.5%(5/7)。我们没有证实钙蛋白的表达与给定、非浸润和浸润性 BCC 亚组之间存在明显的相关性。此外,我们还发现有 7 例 BCC(18.9%)的邻近瘤周基质对钙蛋白有明显的免疫反应。钙蛋白的基质免疫反应与肿瘤生长组织形态学之间存在明显的关联,只有具有浸润性生长特征的 BCC 才会出现阳性反应。我们的研究表明,皮肤 BCC 中的肿瘤细胞通常会产生钙调素,而与组织学亚型无关。钙蛋白在肿瘤组织中的表达与侵袭性肿瘤表型无关。然而,由于一些具有浸润性生长模式的 BCC 在瘤周基质中强烈表达钙调蛋白,因此这一发现可以更可靠地反映癌症的生物学行为,并在未来得到更好的解释。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信